拓新药业:拟设立全资子公司注册资本5000万元
Core Viewpoint - The company has approved the establishment of a wholly-owned subsidiary in Hohhot, Inner Mongolia, focusing on the research, production, and sales of fermentation-related products [1] Group 1 - The company will set up a wholly-owned subsidiary named "Tuo Xin Pharmaceutical (Inner Mongolia) Co., Ltd." with a registered capital of 50 million yuan [1] - The investment for this subsidiary will be fully funded by the company's own or self-raised funds [1] - The company will hold 100% equity in the new subsidiary [1]